Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Moligand™,≥97% Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -20°C,Argon charged Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 4 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
| Canonical Smiles | COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3 |
|---|---|
| IUPAC Name | methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate |
| InChIKey | GKTWGGQPFAXNFI-HNNXBMFYSA-N |
| INCHI | 1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1 |
| Isomeric SMILES | COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3 |
| Alternate CAS | 113665-84-2 |
| NSC Number | 748298 |
| MeSH Entry Terms | clopidogrel;clopidogrel besilate;clopidogrel besylate;clopidogrel bisulfate;clopidogrel hydrochloride;Clopidogrel Mepha;clopidogrel napadisilate;clopidogrel Sandoz;clopidogrel, (+)(S)-isomer;clopidogrel-Mepha;Iscover;PCR 4099;PCR-4099;Plavix;SC 25989C;SC |
| Molecular Weight | 321.82 |
| Reaxy-Rn | 9709294 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=9709294&ln= |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organic acids and derivatives |
| Class | Carboxylic acids and derivatives |
| Subclass | Amino acids, peptides, and analogues |
| Intermediate Tree Nodes | Amino acids and derivatives - Alpha amino acids and derivatives |
| Direct Parent | Alpha amino acid esters |
| Alternative Parents | Thienopyridines Aralkylamines Chlorobenzenes Aryl chlorides Pyridines and derivatives Methyl esters Heteroaromatic compounds Thiophenes Trialkylamines Monocarboxylic acids and derivatives Azacyclic compounds Organochlorides Organic oxides Hydrocarbon derivatives Carbonyl compounds Organopnictogen compounds |
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Alpha-amino acid ester - Thienopyridine - Chlorobenzene - Halobenzene - Aralkylamine - Aryl chloride - Aryl halide - Monocyclic benzene moiety - Pyridine - Benzenoid - Heteroaromatic compound - Methyl ester - Thiophene - Carboxylic acid ester - Tertiary amine - Tertiary aliphatic amine - Monocarboxylic acid or derivatives - Azacycle - Organoheterocyclic compound - Organooxygen compound - Organonitrogen compound - Organochloride - Organohalogen compound - Hydrocarbon derivative - Organic nitrogen compound - Carbonyl group - Organic oxide - Organopnictogen compound - Organic oxygen compound - Amine - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as alpha amino acid esters. These are ester derivatives of alpha amino acids. |
| External Descriptors | methyl ester - monochlorobenzenes - thienopyridine |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Feb 09, 2026 | M637412 | |
| Certificate of Analysis | Feb 09, 2026 | M637412 | |
| Certificate of Analysis | Feb 09, 2026 | M637412 | |
| Certificate of Analysis | Feb 09, 2026 | M637412 | |
| Certificate of Analysis | Sep 10, 2024 | M637412 | |
| Certificate of Analysis | Sep 10, 2024 | M637412 | |
| Certificate of Analysis | Sep 10, 2024 | M637412 | |
| Certificate of Analysis | Sep 10, 2024 | M637412 | |
| Certificate of Analysis | Sep 10, 2024 | M637412 | |
| Certificate of Analysis | Sep 10, 2024 | M637412 | |
| Certificate of Analysis | Sep 10, 2024 | M637412 | |
| Certificate of Analysis | Sep 10, 2024 | M637412 | |
| Certificate of Analysis | Sep 10, 2024 | M637412 | |
| Certificate of Analysis | Sep 10, 2024 | M637412 |
| Sensitivity | Sensitive to humidity;Air sensitive;Heat sensitive |
|---|---|
| Molecular Weight | 321.800 g/mol |
| XLogP3 | 3.800 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 321.059 Da |
| Monoisotopic Mass | 321.059 Da |
| Topological Polar Surface Area | 57.800 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 381.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
| 1. Luyao Ma, Fangjun Yu, Di He, Lianxia Guo, Yu Yang, Wangchun Li, Tianpeng Zhang. (2023) Role of circadian clock in the chronoefficacy and chronotoxicity of clopidogrel. BRITISH JOURNAL OF PHARMACOLOGY, [PMID:37403641] [10.1111/bph.16188] |
| 2. Shuai Ji, Xian Shao, Zhen-yu Su, Lei Ji, Yu-jie Wang, Yun-su Ma, Lu Zhao, Yan Du, Meng-zhe Guo, Dao-quan Tang. (2019) Segmented scan modes and polarity-based LC-MS for pharmacokinetic interaction study between Fufang Danshen Dripping Pill and Clopidogrel Bisulfate Tablet. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, [PMID:31202879] [10.1016/j.jpba.2019.05.055] |
| 3. Bo Fan, Yunfei Li, Yong Bi, Ling Tong, Dongxiang Li, Yi Wang. (2018) Design of multi-drug combinations for poly-pharmacological effects using composition-activity relationship modeling and multi-objective optimization approach: Application in traditional Chinese medicine. Chemical Biology & Drug Design, 93 (6): (1073-1082). [PMID:30230238] [10.1111/cbdd.13396] |
| 4. Zhong Yixin, Ni Qiankun, Huang Liandi, Qing Guangchao, Zhang Fuxue, Gong Ningqiang, Wu Hongyun, Liao Yukun, Jiang Huiting, Tu Zaiqian, Wang Zhifei, Jiramonai Luksika, Zhu Haidong, Teng Gao-Jun, Liang Xing-Jie. (2025) Prevention of acute thrombosis with vascular endothelium antioxidative nanoscavenger. Nature Nanotechnology, [PMID:41174280] [10.1038/s41565-025-02046-4] |
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Moligand™ grade guide →